GABRIELA APARICIO: Open Payments
NPI 1992445928 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,144 in 174 payments from 20 companies in 2025. Trend: 2023 $1,526 · 2024 $4,494 · 2025 $4,144
Food & beverage: $4,137Education: $7
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 15 | $761 |
| ABBVIE INC. | 22 | $597 |
| PFIZER INC. | 11 | $361 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 18 | $321 |
| Janssen Biotech, Inc. | 17 | $319 |
| Regeneron Healthcare Solutions, Inc. | 11 | $283 |
| LEO Pharma Inc. | 13 | $268 |
| UCB, Inc. | 15 | $225 |
| Incyte Corporation | 12 | $220 |
| Novartis Pharmaceuticals Corporation | 11 | $200 |
Products named: Zoryve, TREMFYA, RINVOQ, SKYRIZI, DUPIXENT, ILUMYA, CIBINQO, Bimzelx.
Industry payments across NY — which companies pay providers there.
